Mirum Pharmaceuticals (MIRM) Receivables (2021 - 2026)
Mirum Pharmaceuticals (MIRM) reported Receivables of $145.36 million for Q2 2026, up 36.1% from $106.84 million a year earlier and up 9.2% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Mirum Pharmaceuticals posted Receivables of $123.33 million, up 57.5% from FY2024.
- Receivables has increased for four consecutive years, with a four-year compound annual growth rate of 147.9% (FY2021 to FY2025).
- By year, Receivables came in at $78.29 million in FY2024 (+15.2%), $67.97 million in FY2023 (+183.3%), $23.99 million in FY2022 (+634.4%) and $3.27 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q3 2021.
- Year over year, Receivables has now increased in each of the last 15 quarters, with growth averaging 49.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Receivables ran from 15.2% in Q4 2024 to 634.4% in Q4 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $133.11 million (Q1 2026), $123.33 million (Q4 2025) and $107.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Mirum Pharmaceuticals | 5.70 Bn | 4.11 Bn | 145.90 Mn | 145.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 145.36 Mn |
| Mar 31, 2026 | 133.11 Mn |
| Dec 31, 2025 | 123.33 Mn |
| Sep 30, 2025 | 107.13 Mn |
| Jun 30, 2025 | 106.84 Mn |
| Mar 31, 2025 | 95.85 Mn |
| Dec 31, 2024 | 78.29 Mn |
| Sep 30, 2024 | 68.53 Mn |
| Jun 30, 2024 | 60.43 Mn |
| Mar 31, 2024 | 55.00 Mn |
| Dec 31, 2023 | 67.97 Mn |
| Sep 30, 2023 | 47.83 Mn |
| Jun 30, 2023 | 35.33 Mn |
| Mar 31, 2023 | 24.66 Mn |
| Dec 31, 2022 | 23.99 Mn |
| Sep 30, 2022 | 16.34 Mn |
| Jun 30, 2022 | 13.99 Mn |
| Mar 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 3.27 Mn |
| Sep 30, 2021 | 400,000.00 |
API Access
Mirum Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();